Subscribe free

HPB & Spleen ·

Surgical intervention can lead to statistical cures for HPB cancers.

A systematic review of eleven studies indicates curative-intent surgery for hepato-pancreato-biliary (HPB) cancers can yield statistically significant cures. Hepatocellular carcinoma showed cure fractions of 63.4% to 75.8% with liver transplantation and 31.8% to 40.5% with hepatic resection. Intrahepatic cholangiocarcinoma demonstrated a cure fraction of 9.7% based on tumor stage, while pancreatic neuroendocrine tumors and pancreatic ductal adenocarcinoma had cure fractions of 57.1% and 20.4%, respectively, emphasizing tumor type’s impact on survival.

• Why it matters: Surgery improves survival rates for patients with HPB cancers.

Review by Maspero M, Sposito C (…) Cucchetti A et 2 al. in Dig Liver Dis

Copyright © 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

read the whole article in Dig Liver Dis

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →